Log in to save to my catalogue

The role of advanced glycation end-products and their receptor on outcome in heart failure patients...

The role of advanced glycation end-products and their receptor on outcome in heart failure patients...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_liu_86126

The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction

About this item

Full title

The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction

Publisher

New York, NY: Elsevier Inc

Journal title

The American heart journal, 2012-11, Vol.164 (5), p.742-749.e3

Language

English

Formats

Publication information

Publisher

New York, NY: Elsevier Inc

More information

Scope and Contents

Contents

Introduction Advanced glycation end products (AGEs) are increased in patients with heart failure (HF). We studied the predictive value of plasma AGEs Nε -(carboxymethyl)lysine (CML), pentosidine, and the soluble form of its receptor (sRAGE) in a large HF population. Methods In 580 patients hospitalized with HF, plasma AGEs were measured before disc...

Alternative Titles

Full title

The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_DiVA_org_liu_86126

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_liu_86126

Other Identifiers

ISSN

0002-8703,1097-6744

E-ISSN

1097-6744

DOI

10.1016/j.ahj.2012.07.027